Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRBP Corbus Pharmaceuticals

Market Closed 04-10 16:00:00 EDT

9.80

-0.52

-5.04%

盘后9.80

+0.000.00%

19:20 EDT

High10.31	Low9.56	Vol225.17K
Open10.19	D1 Closing10.32	Amplitude7.22%
Mkt Cap173.82M	Tradable Cap124.93M	Total Shares17.74M
T/O2.21M	T/O Rate1.77%	Tradable Shares12.75M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals","latestPrice":9.8,"timestamp":1775851200000,"preClose":10.32,"halted":0,"volume":225171,"hourTrading":{"tag":"盘后","latestPrice":9.8,"preClose":9.8,"latestTime":"19:20 EDT","volume":105,"amount":1028.81,"timestamp":1775863226052,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.050387596899224764,"floatShares":12747900,"shares":17736464,"eps":-5.899999,"marketStatus":"Market Closed","change":-0.52,"latestTime":"04-10 16:00:00 EDT","open":10.19,"high":10.305,"low":9.56,"amount":2208430.362516,"amplitude":0.07219,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.899999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776067200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":10.32,"preHourTrading":{"tag":"盘前","latestPrice":10.589,"preClose":10.32,"latestTime":"05:21 EDT","volume":1001,"amount":9538.978449,"timestamp":1775812876635,"change":0.269,"changeRate":0.026066,"amplitude":0.103585},"postHourTrading":{"tag":"盘后","latestPrice":9.8,"preClose":9.8,"latestTime":"19:20 EDT","volume":105,"amount":1028.81,"timestamp":1775863226052,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.969901753668664,"impliedVol":0.6608,"impliedVolPercentile":0.256},"requestUrl":"/m/hq/s/CRBP/wiki","defaultTab":"wiki","newsList":[{"id":"2626504153","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2626504153","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626504153?lang=en_us&edition=fundamental","pubTime":"2026-04-10 05:21","pubTimestamp":1775769660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 4.88% to $10.32 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.83% to 22,822.42 and the Dow Jones Industrial Average  rising 0.58% to 48,185.80.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 49.81% below its 52-week high of $20.56, which the company reached on October 20th.The stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  rose 0.55% to $7.33, Fortress Biotech Inc.  rose 3.90% to $2.40, and Viking Therapeutics Inc.  rose 3.80% to $34.95.Trading volume  eclipsed its 50-day average volume of 198,952.Data source: Dow Jones Market Data, FactSet. Data compiled April 9, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is pub","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626806881","title":"Analysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), Corbus Pharmaceuticals (CRBP) and Avita Medical (RCEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626806881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626806881?lang=en_us&edition=fundamental","pubTime":"2026-04-09 21:10","pubTimestamp":1775740226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Treace Medical Concepts (TMCI), Corbus Pharmaceuticals (CRBP) and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-treace-medical-concepts-tmci-corbus-pharmaceuticals-crbp-and-avita-medical-rcel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-treace-medical-concepts-tmci-corbus-pharmaceuticals-crbp-and-avita-medical-rcel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4581","XLV","LU0029874061.USD","CRBP","XBI","BK4585","BK4588","RCEL","TMCI","BK4082","LU0128526141.USD","HCSG","BK4137","BK4539","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626303920","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2626303920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626303920?lang=en_us&edition=fundamental","pubTime":"2026-04-09 05:19","pubTimestamp":1775683140,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 1.34% to $9.84 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 2.80% to 22,635.00 and the Dow Jones Industrial Average  rising 2.85% to 47,909.92.The stock's rise snapped a two-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 52.14% below its 52-week high of $20.56, which the company reached on October 20th.The stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 2.15% to $7.29, Fortress Biotech Inc.  fell 1.70% to $2.31, and Viking Therapeutics Inc.  fell 0.09% to $33.67.Trading volume  eclipsed its 50-day average volume of 198,991.Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is publis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625194654","title":"Corbus Pharmaceuticals (CRBP) Gets a Buy from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2625194654","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625194654?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:55","pubTimestamp":1775649343,"startTime":"0","endTime":"0","summary":"In a report released today, from Wedbush reiterated a Buy rating on Corbus Pharmaceuticals, with a price target of $38.00. In addition to Wedbush, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/corbus-pharmaceuticals-crbp-gets-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/corbus-pharmaceuticals-crbp-gets-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625661859","title":"Corbus Pharmaceuticals Holdings Inc. Stock Slips 4.2%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2625661859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625661859?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:34","pubTimestamp":1775594040,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. slid 4.2% to $9.71 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.1% to 22,017.85 and the Dow Jones Industrial Average falling 0.2% to 46,584.46.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 52.8% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 6.9% to $7.45, Fortress Biotech Inc. fell 6.4% to $2.35, and Viking Therapeutics Inc. fell 0.68% to $33.70.Trading volume totaled 252,116, compared to the 50-day average of 195,951.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625518009","title":"Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Corbus Pharmaceuticals (CRBP) and Artivion (AORT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625518009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625518009?lang=en_us&edition=fundamental","pubTime":"2026-04-07 22:30","pubTimestamp":1775572210,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ionis Pharmaceuticals (IONS), Corbus Pharmaceuticals...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ionis-pharmaceuticals-ions-corbus-pharmaceuticals-crbp-and-artivion-aort-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ionis-pharmaceuticals-ions-corbus-pharmaceuticals-crbp-and-artivion-aort-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","CRBP","IONS","LU0128526141.USD","BK4581","XLV","BK4139","IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4137","XBI","BK4082","HCSG","BK4585","IE00B66KJ199.SGD","AORT","LU0029874061.USD","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625958743","title":"Corbus reports FDA alignment for CRB-701, CMO Dominic Smethurst departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2625958743","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625958743?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:37","pubTimestamp":1775565470,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals (CRBP) announced broad alignment with the FDA on the registration path for CRB-701, the company’s next-generation, highly st...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/corbus-reports-fda-alignment-for-crb-701-cmo-dominic-smethurst-departure-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/corbus-reports-fda-alignment-for-crb-701-cmo-dominic-smethurst-departure-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","LABU","BK4139","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930716","title":"Corbus CMO Dominic Smethurst to step down June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930716","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930716?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:15","pubTimestamp":1775564146,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals disclosed Chief Medical Officer Dominic Smethurst will step down June 30, 2026.Company signaled plans to add several new senior leaders in 2026 as it prepares for late-stage development of lead oncology candidate CRB-701.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDLbS8Trn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625393092","title":"BRIEF-Corbus Pharmaceuticals Announces Broad Alignment With FDA On Registration Path For Crb-701 In Second-Line Hnscc And Cervical Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625393092","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625393092?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:05","pubTimestamp":1775563508,"startTime":"0","endTime":"0","summary":"BRIEF-Corbus Pharmaceuticals Announces Broad Alignment With FDA On Registration Path For Crb-701 In Second-Line Hnscc And Cervical CancerApril 7 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA8XRH9Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625093037","title":"Corbus Pharmaceuticals Holdings Inc - to Continue FDA Interactions to Finalize Registration Study Protocols","url":"https://stock-news.laohu8.com/highlight/detail?id=2625093037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625093037?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA8XRH9Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625674034","title":"Corbus Pharmaceuticals price target raised to $40 from $39 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2625674034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625674034?lang=en_us&edition=fundamental","pubTime":"2026-04-06 21:34","pubTimestamp":1775482443,"startTime":"0","endTime":"0","summary":"Mizuho raised the firm’s price target on Corbus Pharmaceuticals (CRBP) to $40 from $39 and keeps an Outperform rating on the shares. The firm updat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/corbus-pharmaceuticals-price-target-raised-to-40-from-39-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/corbus-pharmaceuticals-price-target-raised-to-40-from-39-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624868772","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2624868772","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624868772?lang=en_us&edition=fundamental","pubTime":"2026-04-03 05:19","pubTimestamp":1775164740,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 1.90% to $10.17 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.18% to 21,879.18 and the Dow Jones Industrial Average  falling 0.13% to 46,504.67.This was the stock's third consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 50.54% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 0.99% to $7.00, Fortress Biotech Inc.  rose 5.26% to $2.60, and Viking Therapeutics Inc.  rose 5.58% to $34.80.Trading volume  eclipsed its 50-day average volume of 190,762.Data source: Dow Jones Market Data, FactSet. Data compiled April 2, 2026.This content was created by MarketWatch, which is operated ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624873296","title":"Corbus Pharmaceuticals announces annual stockholders meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2624873296","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624873296?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:48","pubTimestamp":1775162923,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals scheduled annual stockholder meeting for May 13, 2026, to be held online.Shareholders will vote on election of six directors to serve until next annual meeting.Ballot includes amendment to 2024 Equity Compensation Plan to raise authorized shares by 3,000,000 to 5,000,000.Items also include ratification of EisnerAmper as independent auditor for fiscal 2026.Advisory votes will cover executive compensation plus preferred frequency for future say-on-pay votes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exch","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL4jcRFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624509378","title":"Mizuho Securities Sticks to Their Buy Rating for Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624509378","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624509378?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:15","pubTimestamp":1775132148,"startTime":"0","endTime":"0","summary":"In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Corbus Pharmaceuticals, with a price target of $40....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624506863","title":"Mizuho Lifts Price Target on Corbus Pharmaceuticals Holdings to $40 From $39, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2624506863","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624506863?lang=en_us&edition=fundamental","pubTime":"2026-04-02 19:55","pubTimestamp":1775130945,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings (CRBP) has an average rating of buy and mean price target of $42.11, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MFG","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624183541","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises 6.3%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2624183541","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624183541?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:34","pubTimestamp":1775075640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. rallied 6.3% to $9.98 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.2% to 21,840.95 and the Dow Jones Industrial Average rising 0.5% to 46,565.74.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 51.5% short of its 52-week high of $20.56, which the company reached on October 20th.The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 2.3% to $7.07, Fortress Biotech Inc. fell 11.5% to $2.47, and Viking Therapeutics Inc. rose 1.29% to $32.96.Trading volume totaled 201,493, compared to the 50-day average of 189,522.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623321031","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2623321031","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623321031?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:21","pubTimestamp":1774905660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 1.26% to $8.60 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.11% to 45,216.14 and the NASDAQ Composite Index  falling 0.73% to 20,794.64.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 58.17% below its 52-week high of $20.56, which the company achieved on October 20th.Despite its losses, the stock outperformed some of its competitors Monday, as Vanda Pharmaceuticals Inc.  fell 3.76% to $6.65, Fortress Biotech Inc.  fell 2.17% to $2.70, and Viking Therapeutics Inc.  fell 8.00% to $29.92.Trading volume  remained 39,631 below its 50-day average volume of 186,585.Data source: Dow Jones Market Data, FactSet. Data compiled March 30, 2026.This content was created by MarketWatch, which is operated by Dow Jo","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622808261","title":"Corbus Pharmaceuticals Holdings Inc. Stock Slides 5.7%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2622808261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622808261?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:34","pubTimestamp":1774643640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. shed 5.7% to $8.71 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 2.1% to 20,948.36 and Dow Jones Industrial Average falling 1.7% to 45,166.64.The stock's fall snapped a two-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 57.6% below its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 2.9% to $6.91, Fortress Biotech Inc. fell 4.2% to $2.76, and Viking Therapeutics Inc. fell 5.05% to $32.52.Trading volume totaled 214,722, compared to the 50-day average of 187,327.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622007784","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007784?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:21","pubTimestamp":1774473660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 1.59% to $8.31 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.77% to 21,929.83 and the Dow Jones Industrial Average  rising 0.66% to 46,429.49.The stock's rise snapped a five-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 59.58% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 6.30% to $7.25, Fortress Biotech Inc.  rose 2.40% to $2.99, and Viking Therapeutics Inc.  rose 3.20% to $33.20.Trading volume  eclipsed its 50-day average volume of 185,074.Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. Ma","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621193066","title":"Corbus Pharmaceuticals Holdings Repeat Insider Selling Not A Positive Indicator","url":"https://stock-news.laohu8.com/highlight/detail?id=2621193066","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621193066?lang=en_us&edition=fundamental","pubTime":"2026-03-24 18:38","pubTimestamp":1774348737,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings, Inc. ( NASDAQ:CRBP ) shareholders might have a reason to worry after multiple insiders...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crbp/corbus-pharmaceuticals-holdings/news/corbus-pharmaceuticals-holdings-repeat-insider-selling-not-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crbp/corbus-pharmaceuticals-holdings/news/corbus-pharmaceuticals-holdings-repeat-insider-selling-not-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0364},{"period":"1month","weight":-0.0604},{"period":"3month","weight":0.1793},{"period":"6month","weight":-0.3694},{"period":"1year","weight":0.7223},{"period":"ytd","weight":0.2039}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.363358},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.048678},{"month":3,"riseRate":0.636364,"avgChangeRate":0.197993},{"month":4,"riseRate":0.545455,"avgChangeRate":0.045702},{"month":5,"riseRate":0.636364,"avgChangeRate":0.079186},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.065346},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.050382},{"month":8,"riseRate":0.636364,"avgChangeRate":0.095672},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.086452},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.124298},{"month":11,"riseRate":0.727273,"avgChangeRate":0.130055},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.132264}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corbus Pharmaceuticals,CRBP,Corbus Pharmaceuticals股票,Corbus Pharmaceuticals股票老虎,Corbus Pharmaceuticals股票老虎国际,Corbus Pharmaceuticals行情,Corbus Pharmaceuticals股票行情,Corbus Pharmaceuticals股价,Corbus Pharmaceuticals股市,Corbus Pharmaceuticals股票价格,Corbus Pharmaceuticals股票交易,Corbus Pharmaceuticals股票购买,Corbus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction